Hasanzad Mandana, Aghaei Meybodi Hamid Reza, Sarhangi Negar, Larijani Bagher
Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2022 Jan 11;21(1):971-978. doi: 10.1007/s40200-021-00949-2. eCollection 2022 Jun.
In recent years, artificial intelligence (AI) shows promising results in the diagnosis, prediction, and management of diseases. The move from handwritten medical notes to electronic health records and a huge number of digital data commenced in the era of big data in medicine. AI can improve physician performance and help better clinical decision making which is called augmented intelligence. The methods applied in the research of AI and endocrinology include machine learning, artificial neural networks, and natural language processing. Current research in AI technology is making major efforts to improve decision support systems for patient use. One of the best-known applications of AI in endocrinology was seen in diabetes management, which includes prediction, diagnosis of diabetes complications (measuring microalbuminuria, retinopathy), and glycemic control. AI-related technologies are being found to assist in the diagnosis of other endocrine diseases such as thyroid cancer and osteoporosis. This review attempts to provide insight for the development of prospective for AI with a focus on endocrinology.
近年来,人工智能(AI)在疾病的诊断、预测和管理方面显示出了令人鼓舞的成果。从手写病历到电子健康记录的转变以及大量数字数据的出现始于医学大数据时代。人工智能可以提高医生的工作表现,并有助于做出更好的临床决策,这被称为增强智能。人工智能与内分泌学研究中应用的方法包括机器学习、人工神经网络和自然语言处理。目前人工智能技术的研究正在大力改进供患者使用的决策支持系统。人工智能在内分泌学中最著名的应用之一见于糖尿病管理,其中包括糖尿病并发症的预测、诊断(测量微量白蛋白尿、视网膜病变)以及血糖控制。人们发现与人工智能相关的技术有助于诊断其他内分泌疾病,如甲状腺癌和骨质疏松症。本综述旨在为人工智能的未来发展提供见解,重点关注内分泌学。